Literature DB >> 10075840

A hypomorphic myogenin allele reveals distinct myogenin expression levels required for viability, skeletal muscle development, and sternum formation.

J L Vivian1, L Gan, E N Olson, W H Klein.   

Abstract

The myogenic basic helix-loop-helix transcription factor myogenin plays an essential role in the differentiation of skeletal muscle and, secondarily, in rib and sternum formation during mouse development. However, virtually nothing is known about the quantitative requirements for myogenin in these processes. Here, we describe the generation of mice carrying a hypomorphic allele of myogenin, which expresses myogenin transcripts at approximately one-fourth the level of the wild-type myogenin allele. The hypomorphic allele in combination with wild-type and myogenin-null alleles was used to create an allelic series. Embryos representing the complete range of genotypes from homozygous wild type to homozygous null were analyzed for their viability, ability to form normal ribs and sternum, and extent of skeletal muscle differentiation. Embryos carrying the hypomorphic myogenin allele over a wild-type allele were normal. In embryos bearing homozygous hypomorphic alleles, the sternum developed normally and extensive skeletal muscle differentiation occurred. However, muscle hypoplasia and reduced muscle-specific gene expression were apparent in these embryos, and the mice were not viable as neonates. When the hypomorphic allele was placed over a myogenin-null allele, the resulting embryos had sternum defects resembling homozygous myogenin-null embryos, and there was severe muscle hypoplasia. Our results demonstrate that skeletal muscle formation is highly sensitive to the absolute levels of myogenin and that correct sternum formation, skeletal muscle differentiation, and viability each require distinct threshold levels of myogenin. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075840     DOI: 10.1006/dbio.1998.9182

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  7 in total

1.  A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration.

Authors:  Merhnaz Ghazvini; Wim Mandemakers; Martine Jaegle; Marko Piirsoo; Siska Driegen; Manousos Koutsourakis; Xsander Smit; Frank Grosveld; Dies Meijer
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

2.  miR-92b regulates Mef2 levels through a negative-feedback circuit during Drosophila muscle development.

Authors:  Zhimin Chen; Shanshan Liang; Ying Zhao; Zhe Han
Journal:  Development       Date:  2012-08-16       Impact factor: 6.868

3.  Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1.

Authors:  Christina Wei; Lauren Stock; Leila Valanejad; Zachary A Zalewski; Rebekah Karns; Jack Puymirat; David Nelson; David Witte; Jim Woodgett; Nikolai A Timchenko; Lubov Timchenko
Journal:  FASEB J       Date:  2018-01-05       Impact factor: 5.191

4.  Myogenin regulates denervation-dependent muscle atrophy in mouse soleus muscle.

Authors:  Peter C D Macpherson; Xun Wang; Daniel Goldman
Journal:  J Cell Biochem       Date:  2011-08       Impact factor: 4.429

5.  The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo.

Authors:  Frédéric Relaix; Mariarosa Polimeni; Didier Rocancourt; Carola Ponzetto; Beat W Schäfer; Margaret Buckingham
Journal:  Genes Dev       Date:  2003-12-01       Impact factor: 11.361

6.  mef2 activity levels differentially affect gene expression during Drosophila muscle development.

Authors:  Stuart J Elgar; Jun Han; Michael V Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-15       Impact factor: 11.205

7.  Reduction of Ptf1a gene dosage causes pancreatic hypoplasia and diabetes in mice.

Authors:  Akihisa Fukuda; Yoshiya Kawaguchi; Kenichiro Furuyama; Sota Kodama; Masashi Horiguchi; Takeshi Kuhara; Michiya Kawaguchi; Mami Terao; Ryuichiro Doi; Christopher V E Wright; Mikio Hoshino; Tsutomu Chiba; Shinji Uemoto
Journal:  Diabetes       Date:  2008-06-30       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.